Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67251 - 67275 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	SCARB1	949	upregulated	rosiglitazone results in increased expression of SCARB1 mRNA	12q24.31	A20966
Rosiglitazone	Approved Investigational	SCD	6319	upregulated	rosiglitazone results in increased expression of SCD mRNA	10q24.31	A24140 A23178 A24112 A24141
Rosiglitazone	Approved Investigational	SCP2	6342	downregulated	rosiglitazone results in decreased expression of SCP2 mRNA	1p32.3	A22609
Rosiglitazone	Approved Investigational	SEL1L3	23231	upregulated	rosiglitazone results in increased expression of SEL1L3 mRNA	4p15.2	A10216
Rosiglitazone	Approved Investigational	SELP	6403	downregulated	rosiglitazone results in decreased expression of SELP mRNA	1q24.2	A24143
Rosiglitazone	Approved Investigational	SELPLG	6404	downregulated	rosiglitazone results in decreased expression of SELPLG mRNA	12q24.11	A10216
Rosiglitazone	Approved Investigational	SERINC2	347735	upregulated	rosiglitazone results in increased expression of SERINC2 mRNA	1p35.2	A22609
Rosiglitazone	Approved Investigational	SERPINA4	5267	downregulated	rosiglitazone results in decreased expression of SERPINA4 mRNA	14q32.13	A22609
Rosiglitazone	Approved Investigational	SERPINE1	5054	downregulated	rosiglitazone results in decreased expression of SERPINE1 mRNA	7q22.1	A21419
Rosiglitazone	Approved Investigational	SERPINE1	5054	upregulated	rosiglitazone results in increased expression of SERPINE1 mRNA	7q22.1	A23656
Rosiglitazone	Approved Investigational	SERPINF1	5176	downregulated	rosiglitazone results in decreased expression of SERPINF1 mRNA	17p13.3	A22609
Rosiglitazone	Approved Investigational	SH3TC1	54436	upregulated	rosiglitazone results in increased expression of SH3TC1 mRNA	4p16.1	A20427
Rosiglitazone	Approved Investigational	SHD	56961	downregulated	rosiglitazone results in decreased expression of SHD mRNA	19p13.3	A22609
Rosiglitazone	Approved Investigational	SIGLEC17P	284367	upregulated	rosiglitazone results in increased expression of SIGLEC17P mRNA	19q13.41	A10216
Rosiglitazone	Approved Investigational	SIK1	150094	upregulated	rosiglitazone results in increased expression of SIK1 mRNA	21q22.3	A20427
Rosiglitazone	Approved Investigational	SIRPB1	10326	upregulated	rosiglitazone results in increased expression of SIRPB1 mRNA	20p13	A10216
Rosiglitazone	Approved Investigational	SKAP1	8631	downregulated	rosiglitazone results in decreased expression of SKAP1 mRNA	17q21.32	A22609
Rosiglitazone	Approved Investigational	SLC22A1	6580	downregulated	rosiglitazone results in decreased expression of SLC22A1 mRNA	6q25.3	A22609
Rosiglitazone	Approved Investigational	SLC22A10	387775	downregulated	rosiglitazone results in decreased expression of SLC22A10 mRNA	11q12.3	A22609
Rosiglitazone	Approved Investigational	SLC22A18AS	5003	downregulated	rosiglitazone results in decreased expression of SLC22A18AS mRNA	11p15.4	A22609
Rosiglitazone	Approved Investigational	SLC22A5	6584	upregulated	rosiglitazone results in increased expression of SLC22A5 mRNA	5q31.1	A22609
Rosiglitazone	Approved Investigational	SLC22A7	10864	downregulated	rosiglitazone results in decreased expression of SLC22A7 mRNA	6p21.1	A22609
Rosiglitazone	Approved Investigational	SLC22A9	114571	downregulated	rosiglitazone results in decreased expression of SLC22A9 mRNA	11q12.3	A22609
Rosiglitazone	Approved Investigational	SLC25A20	788	downregulated	rosiglitazone results in decreased expression of SLC25A20 mRNA	3p21.31	A20427
Rosiglitazone	Approved Investigational	SLC25A26	115286	upregulated	rosiglitazone results in increased expression of SLC25A26 mRNA	3p14.1	A22609

Displaying entries 67251 - 67275 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability